In the current month, RNAZ has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RNAZ average Analyst price target in the last month is 10.000.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
Strong Buy
0
0
0
0
0
0
0
0
Buy
0
0
0
0
0
0
0
0
Hold
0
0
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
0
0
0
0
0
0
0
0
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
Forecast
--
--
--
Actual
-16.49
-21.28
-7.17
Surprise
--
--
--
FAQs
What is Transcode Therapeutics Inc's price target?
Analysts forecast that Transcode Therapeutics Inc's price target is USD 10.00, with the highest forecast at USD 10.00 and the lowest forecast at USD 10.00.